Close Menu

Precipio

NEW YORK (GenomeWeb News) – Transgenomic today announced an agreement to provide genetic testing services for Raptor Pharmaceuticals' clinical trial evaluating its drug called RP103 as a potential treatment for Leigh syndrome and other inherited mitochondrial disorders.

A Phase II study comparing front-line treatment with anti-EGFR drug Vectibix against anti-VEGF therapy Avastin in a genetically defined subset of metastatic colorectal cancer patients has yielded promising results in favor of the anti-EGFR agent.

NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market Wednesday that its fourth quarter revenues fell 12 percent year over year.

NEW YORK (GenomeWeb News) – Transgenomic today said that it expects to raise $7 million in gross proceeds from the sale of 1,443,297 convertible preferred shares.

NEW YORK (GenomeWeb News) — Transgenomic said today that it has filed an application to list its common shares on the Nasdaq Capital Market, and that it will initiate a 1-for-12 reverse stock split.

NEW YORK (GenomeWeb News) – Transgenomic said today that it has expanded a national contractual agreement with the Blue Cross and Blue Shield Association.

Transgenomic has appointed Stephen Miller senior vice president and general manager of its patient testing business unit.

Transgenomic has appointed Stephen Miller as senior vice president and general manager of its patient testing business unit.

NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market on Wednesday that its sales in the third quarter fell 16 percent year over year.

NEW YORK (GenomeWeb News) – Personalized medicine firm Transgenomic today announced that it has signed a deal under which PerkinElmer will market and distribute its portfolio of molecular diagnostic oncology products in all markets outside the US.

Pages

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.